WIRE — La biotecnológica chilena que realiza I+D con hongos entrará al retail londinense en el segundo semestre y, en paralelo, debutará en el desarrollo de fármacos y proteínas.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.